As on Wednesday, Alx Oncology Holdings Inc (NASDAQ: ALXO) started slowly as it slid -10.50% to $5.88, before settling in for the price of $6.57 at the close. Taking a more long-term approach, ALXO posted a 52-week range of $3.94-$17.83.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -8.67%. Meanwhile, its Annual Earning per share during the time was -50.98%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 24.01%. This publicly-traded company’s shares outstanding now amounts to $49.95 million, simultaneously with a float of $29.77 million. The organization now has a market capitalization sitting at $306.35 million. At the time of writing, stock’s 50-day Moving Average stood at $12.62, while the 200-day Moving Average is $11.46.
Alx Oncology Holdings Inc (ALXO) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Alx Oncology Holdings Inc’s current insider ownership accounts for 42.86%, in contrast to 56.39% institutional ownership. According to the most recent insider trade that took place on Jun 13 ’24, this organization’s CHIEF FINANCIAL OFFICER bought 12,000 shares at the rate of 8.53, making the entire transaction reach 102,338 in total value, affecting insider ownership by 122,348. Preceding that transaction, on Jun 04 ’24, Company’s PRESIDENT & CSO sold 20,000 for 8.43, making the whole transaction’s value amount to 168,652. This particular insider is now the holder of 604,205 in total.
Alx Oncology Holdings Inc (ALXO) Earnings and Revenue Records
If we go through the results of last quarter, which was made public on 3/31/2024, the company posted -0.84 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.88) by 0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.71 per share during the current fiscal year.
Alx Oncology Holdings Inc’s EPS increase for this current 12-month fiscal period is 24.01% and is forecasted to reach -2.81 in the upcoming year.
Alx Oncology Holdings Inc (NASDAQ: ALXO) Trading Performance Indicators
Let’s observe the current performance indicators for Alx Oncology Holdings Inc (ALXO). It’s Quick Ratio in the last reported quarter now stands at 5.21. The Stock has managed to achieve an average true range (ATR) of 0.84.
In the same vein, ALXO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.71, a figure that is expected to reach -0.74 in the next quarter, and analysts are predicting that it will be -2.81 at the market close of one year from today.
Technical Analysis of Alx Oncology Holdings Inc (ALXO)
Through scrutinizing the latest numbers posted by the [Alx Oncology Holdings Inc, ALXO], it can be observed that its last 5-days Average volume of 1.1 million was better the volume of 0.56 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 10.72% While, its Average True Range was 0.77.
Raw Stochastic average of Alx Oncology Holdings Inc (ALXO) in the period of the previous 100 days is set at 2.15%, which indicates a major fall in contrast to 6.93% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 60.57% that was lower than 88.62% volatility it exhibited in the past 100-days period.
